Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

UCL Technology Fund

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 19
Rounds per year 4.17
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.24
Exits 4
Key employees 1

Areas of investment

  • Biotechnology
  • Artificial Intelligence
  • Health Care
  • Machine Learning
  • Software
Summary

The leading representative office of defined VC is situated in the London. The company was established in Europe in United Kingdom.

The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Opposing the other organizations, this UCL Technology Fund works on 9 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2018.

Among the various public portfolio startups of the fund, we may underline Orchard Therapeutics, Hazy, MediaGamma Among the most popular fund investment industries, there are Genetics, Artificial Intelligence. The fund has exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

The overall number of key employees were 1.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the UCL Technology Fund, startups are often financed by UCLB, Syncona Partners LLP, Nesta Impact Investments. The meaningful sponsors for the fund in investment in the same round are London Co-Investment Fund, AI Seed, UCLB. In the next rounds fund is usually obtained by Syncona Partners LLP, Venrock, UCLB.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of UCL Technology Fund:
Typical Co-investors
UCL Technology Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after UCL Technology Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anna Partners Israel, Tel Aviv, Tel Aviv District
Buongiorno Emilia-Romagna, Italy, Parma
Canson Capital Partners England, London, United Kingdom
Dresdner Kleinwort England, London, United Kingdom
FountainVest Partners China, Hong Kong, Hong Kong Island
Goldman Sachs Asset Management New York, New York, United States
Hengjian Holding China, Guangdong Province, Huizhou
Hoshino Resorts Japan, Nagano, Nagano Prefecture
Huashu Chuanmei China, Hangzhou, Zhejiang
Ingram Content Group La Vergne, Tennessee, United States
Lantern Capital Central, Central Region, Singapore
Merck Capital Ventures New Jersey, United States, Woodcliff Lake
Sharrp Ventures India, Maharashtra, Mumbai
Shibolet Capital Israel, Tel Aviv, Tel Aviv District
SRB Management Dallas, Texas, United States
Technostarters Fonds Zuid-Nederland B.V. Eindhoven, Noord-Brabant, The Netherlands
The Bonte Family Fund -
The Hale Group Danvers, Massachusetts, United States
TransLink British Columbia, Burnaby, Canada

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Bramble Energy

Clean Energy
CleanTech
Consumer Electronics
Energy
Fuel Cell
Manufacturing
Renewable Energy
$47M14 Feb 2022 London, England, United Kingdom

Carbon Re

Artificial Intelligence
Machine Learning
Manufacturing
Software
$1M20 Oct 2021 London, England, United Kingdom

Apollo Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$137M17 Jun 2021 United Kingdom, England, United Kingdom

Intrinsic Semiconductor Technologies

Artificial Intelligence
Electronics
Information Technology
Manufacturing
Semiconductor
$1M22 Mar 2021 London, England, United Kingdom

Quell Therapeutics

Association
Biotechnology
Education
$40M11 Feb 2021 United Kingdom, England

Nozzle.ai

Advertising
E-Commerce
Software
$2M18 Nov 2020 London, England, United Kingdom

Bramble Energy

Clean Energy
CleanTech
Consumer Electronics
Energy
Fuel Cell
Manufacturing
Renewable Energy
$6M03 Aug 2020 London, England, United Kingdom

Humanloop

Artificial Intelligence
Human Computer Interaction
Machine Learning
29 Jul 2020 London, England, United Kingdom

AstronauTx

Pharmaceutical
$1M24 Mar 2020 United Kingdom, England, United Kingdom
News
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

– Apollo Therapeutics completed a $145m financing round.
– The round was led by Patient Square Capital and included participation from Rock Springs Capital, Reimagined Ventures and UCL Technology Fund.
– Apollo is a portfolio-based biopharmaceutical company rapidly advancing potentially transformative treatments based on breakthrough discoveries.
– Apollo is set-up to bridge the gap from deep academic science to patient benefit in the most capital and time efficient way possible.
– Apollo seeks to develop therapeutics that have transformative potential above the current standard of care.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent UCL Technology Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: